Steadtrust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Steadtrust's BMY Position: Q2 2026 in Review
Steadtrust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 11,732 shares worth $676K. The position accounts for 0.34% of the portfolio, ranked #68.
Steadtrust first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $712K in Q1 2026. 2,503 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Steadtrust held 11,732 shares of Bristol-Myers Squibb worth $676K as of Q2 2026.
- Steadtrust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.34% of Steadtrust's portfolio in Q2 2026, its #68 holding.
- Steadtrust first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Steadtrust's Bristol-Myers Squibb position peaked at $712K in Q1 2026.
- 2,503 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.